Salmon-Céron, Dominique <br/><br/>
Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  May 2003 
 - 1295-304 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-6591 
<br/><br/><label>Standard No.: </label>10.1086/374837  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>CD4 Lymphocyte Count<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>HIV Infections--blood<br/>HIV-1--drug effects<br/>Hepacivirus--drug effects<br/>Hepatitis C<br/>Hepatitis C, Chronic--blood<br/>Humans<br/>Interferons--therapeutic use<br/>Male<br/>Middle Aged<br/>RNA, Viral--blood<br/>Ribavirin--therapeutic use<br/>Stavudine--pharmacokinetics<br/>Treatment Outcome<br/>Viral Load